CD137 Antibodies Clinical Trials & Market Opportunity - Revolutionary CD137 Antibodies Poised to Transform Cancer Immunotherapy Landscape by 2027
September 12, 2024 04:01 ET
|
Research and Markets
Dublin, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The "CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027" report has been added to ResearchAndMarkets.com's offering. CD137, also...
CD40 Ligand Market - Global Monoclonal Antibody, Polyclonal Antibody, Autoimmune Disease Treatment, Immunotherapy, Vaccine Development Forecast 2024-2030
August 30, 2024 04:04 ET
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global CD40 Ligand Market by Type (Monoclonal Antibody, Polyclonal Antibody), Application (Autoimmune Disease Treatment, Immunotherapy, Vaccine...
Anti TIGIT Antibodies Clinical Trials Market Outlook to 2028: Insight on 50+ Anti TIGIT Antibodies in Clinical Trials
August 09, 2024 05:22 ET
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering. Anti TIGIT...
Trispecific Antibodies Clinical Trials & Market Outlook Report 2024: Innovative Trispecific Antibody Therapy - A New Frontier in Cancer and Disease Treatment
August 09, 2024 04:19 ET
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Trispecific Antibodies Clinical Trials & Market Outlook 2024" report has been added to ResearchAndMarkets.com's offering.The blueprint in...
Trispecific Antibodies Set to Transform the Future of Immunotherapy: Trispecific Antibodies Clinical Trials Insight by Company, Country, Indication & Phase
June 07, 2024 02:59 ET
|
Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Global Trispecific Antibodies Clinical Trials & Market Outlook 2024" report has been added to ResearchAndMarkets.com's offering. The blueprint...
World Immuno-Oncology Diagnostics Market Forecasts Report 2024: The Disruption Dynamic, The Race for Biomarkers, The Next Five Years
May 28, 2024 09:06 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis" report has been added to ...
Global Liver Cancer Drug Market to Reach USD 7.83 Billion by 2030: Innovative treatments like oncolytic viruses and RNA interference (RNAi) have gained market traction
April 10, 2024 04:04 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Liver Cancer Drug Market Size, Share & Trends Analysis Report By Drug Class (Targeted Therapy, Immunotherapy, Chemotherapy), By Region, And...
Innovation Waves in Immuno-oncology Therapy Development - Next-gen Cell Therapies and Precision Immunotherapies are Driving Growth and New Product Development
March 21, 2024 05:13 ET
|
Research and Markets
Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "Innovation Waves in Immuno-oncology Therapy Development" report has been added to ResearchAndMarkets.com's offering. Immuno-oncology (I-O)...
Cancer Immunotherapy Market Research 2024: The Race for the Cures - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer including Executive and Consultant Guides
March 13, 2024 11:26 ET
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Markets. The Race for the Cures. Market Forecasts for Immuno-Oncology Therapeutics by Therapy, by Cancer and by Customer...
Next-Gen Immuno-Oncology Conference, 7th-8th March 2024 (London, UK) - One Week to Go
February 28, 2024 04:01 ET
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "8th Annual Next-Gen Immuno-Oncology Conference" has been added to ResearchAndMarkets.com's offering. Leading the Immunotherapy Revolution -...